Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2019-03-11 2019-03-11
Drug Identification Number 02427931 02427931
Brand name APO-NEVIRAPINE XR APO-NEVIRAPINE XR
Common or Proper name NEVIRAPINE NEVIRAPINE
Company Name APOTEX INC APOTEX INC
Ingredients NEVIRAPINE NEVIRAPINE
Strength(s) 400MG 400MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 30 BLS 30 BLS
ATC code J05AG J05AG
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-03-08 2019-03-08
Remaining supply date 2019-03-08 2019-03-08
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments